Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
7 hedge funds and large institutions have $6.65M invested in Forward Pharma A/S American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
16% more capital invested
Capital invested by funds: $5.73M → $6.65M (+$926K)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$128K |
| 2 |
Renaissance Technologies
New York
|
+$120K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$83K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.72K |
FWP Hedge Fund Activity: Q4 2020 in Review
7 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2020, worth a combined $6.65M — up 16% from $5.73M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FWP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Morgan Stanley, adding an estimated $128K. The largest seller was HRT Financial, exiting entirely with an estimated $83K sold.
- 7 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2020, down from 8 in Q3 2020.
- Funds reported $6.65M of Forward Pharma A/S American Depositary Shares stock for Q4 2020, up 16% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q4 2020 and 1 closed out, a net change of -1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q4 2020 was Morgan Stanley, an estimated $128K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q4 2020 was HRT Financial, an estimated $83K sold.
Based on aggregated 13F filings for Q4 2020.